The Efficacy and Safety of IBI363 in Solid Tumors

NCT06081907 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

430

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: IBI363
DRUG: IBI363
DRUG: IBI363
DRUG: IBI363
DRUG: IBI363

Sponsor

Hunan Province Tumor Hospital

Collaborators

[object Object]